Portfolio

Science with a path to
clinical relevance.

We invest in and create companies developing new medicines across therapeutic areas and modalities.

Co-created · Metabolic diseaseClinical stage

Resalis Therapeutics

Advancing first-in-class non-coding RNA medicines for obesity and metabolic disease.

Company profile ↗
Co-created · NeuroscienceClinical stage

IAMA Therapeutics

Restoring neuronal chloride homeostasis in serious central nervous system disorders.

Company profile ↗
Investment · RespiratoryClinical stage

Kither Biotech

Developing new therapies for severe respiratory diseases.

Company profile ↗
Co-created · OncologyClinical stage

ALKemist Bio

Developing next-generation CAR-T and TCR-T cell therapies for solid tumours.

Company profile ↗
Investment · Protein degradationPreclinical stage

Sibylla Biotech

Discovering small-molecule therapeutics through a differentiated protein-folding approach.

Company profile ↗
Investment · OncologyPreclinical stage

NeoPhore

Developing precision medicines designed to stimulate anti-tumour immunity.

Company profile ↗
Co-created · OncologyPreclinical stage

Repron Therapeutics

Exploring new therapeutic approaches at the intersection of RNA biology and cancer.

Company profile ↗
Co-created · OncologyPreclinical stage

PAGE Therapeutics

Advancing a new precision-oncology programme derived from differentiated cancer biology.

Company profile ↗
Co-created · CardiovascularPreclinical stage

Heqet Therapeutics

Developing RNA-based therapies to induce cardiac regeneration.

Company profile ↗
Co-created · OncologyPreclinical stage

Lever Bio

Reprogramming the solid tumour microenvironment to unlock the full potential of cancer immunotherapy.

Company profile ↗
Co-created · OncologyDiscovery stage

Haptena Therapeutics

Developing next-generation immunotherapies for oncogene-driven cancers, integrating precision oncology and immune engineering.

Company profile ↗
Co-created · ImmunologyDiscovery stage

Shadow Therapeutics

An immunology programme currently operating in stealth mode.

Company profile ↗
Start a conversation

Exceptional science deserves the right investor.

Scientists & foundersShare a therapeutic opportunity or introduce us to your company.↗ Investors & industryConnect with our investment team.↗ Talent & expertsExplore opportunities across Claris and our portfolio network.→